[HTML] springer.comFull View

[HTML][HTML] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

X Li, Y Song - Journal of hematology & oncology, 2020 - Springer
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …
被引用次数：278 相关文章

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy.

X Li, Y Song - Journal of Hematology & Oncology, 2020 - search.ebscohost.com
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …

[引用][C] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

X Li, Y Song - Journal of Hematology & Oncology (Web), 2020 - jglobal.jst.go.jp
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer
therapy | Article Information | J-GLOBAL Art J-GLOBAL ID:202102249483830014 …

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

X Li, Y Song - Journal of hematology & oncology, 2020 - pubmed.ncbi.nlm.nih.gov
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …
[HTML] biomedcentral.com

[HTML][HTML] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

X Li, Y Song - Journal of Hematology & Oncology, 2020 - jhoonline.biomedcentral.com
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …
[HTML] nih.gov

[HTML][HTML] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

X Li, Y Song - Journal of Hematology & Oncology, 2020 - ncbi.nlm.nih.gov
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy.

X Li, Y Song - Journal of Hematology & Oncology, 2020 - europepmc.org
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

X Li, Y Song - Journal of Hematology and Oncology, 2020 - hero.epa.gov
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

X Li, Y Song - Journal of Hematology & Oncology, 2020 - search.proquest.com
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy.

X Li, Y Song - Journal of Hematology & Oncology, 2020 - go.gale.com
Proteolysis-targeting chimera (PROTAC) has been developed to be a useful technology for
targeted protein degradation. A bifunctional PROTAC molecule consists of a ligand (mostly …